Bristlecone Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bristlecone Advisors's GILD Position: Q4 2020 in Review
Bristlecone Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 17,124 shares — an estimated $1.08M sold.
Bristlecone Advisors first reported a position in GILD in Q4 2015 and held it in 19 quarters. The position peaked at $2.38M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Bristlecone Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Bristlecone Advisors sold 17,124 Gilead Sciences shares in Q4 2020, an estimated $1.08M.
- Bristlecone Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 19 quarters.
- Bristlecone Advisors's Gilead Sciences position peaked at $2.38M in Q4 2015.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Bristlecone Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.